510(k) Report

FDA applicant

Beckman Coulter Ireland, Inc.

Co. Clare, IE7 decisions2013–20194 recalls

FDA records 7 decisions for Beckman Coulter Ireland, Inc. (Co. Clare, IE) from 2013 to 2019: 7 510(k) clearances. Most are in product codes JZG (System, Test, Beta-2-Microglobulin Immunological) and JIX (Calibrator, Multi-Analyte Mixture). Its devices cite 8 predicates, 0 of them its own earlier devices. 4 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Beckman Coulter Ireland, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2019

2013: 12014: 32016: 12017: 12019: 1
2013high 3 (2014) · low 0 (2015)2026

2026 so far, outlined.

Recalls per year

1in 2025

2023: 32025: 1
2013high 3 (2023) · low 0 (2013)2026

Class I Class II/III not classified

FIG. 1 — Beckman Coulter Ireland, Inc. by year, 2013–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Beckman Coulter Ireland, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Beckman”

FDA records each applicant name separately; these may or may not be the same firm.